Specializing in low-frequency mutant molecule detection, our top-tier CLIA lab works tirelessly to accelerate your discovery process. Uncover accurate data, found the first time.
Get to know us
Every life has boundless potential.
As a world-class CLIA lab, we pave the way to personal, accurate treatment through ultra-sensitive liquid biopsy and biomarker analysis. We're here so diseases like cancer don't get the last say. We're here for our families, colleagues, and friends. We believe each of us has a unique story to tell, so we test to track every molecule, changing outcomes for the better.
SYSMEX x QIAGEN
We joined forces with QIAGEN, another world-class company, to accelerate global CDx access. Our collective expertise allows us to anticipate and understand your specific needs throughout the clinical trial process.
Why Sysmex Inostics?
It empowers more accurate detection of low-frequency biomarkers from a simple blood draw. Expedite your studies and uncover deeper insights into therapy response. Our testing technologies are optimized for ultra-sensitivity with high specificity and efficiency.
Test with us
Less invasive. Less time. More confidence.
Partner with our lab for sensitivity, service, and accuracy — without the exponential cost.
Latest news & publications
Blog | Aug. 30, 2023
MRD in AML: the next step in fighting leukemia
Press Release | Apr. 13, 2023
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery a...
Blog | Feb. 01, 2023
Sysmex Inostics industry-leading sensitivity for liquid biopsy
Press Release | Apr. 17, 2023
Sysmex Inostics Exhibits at American Association for Cancer Research Annual Meeting 2023 in Orlando
Blog | Apr. 10, 2023
Liquid biopsy with Plasma-Safe-SeqS
Blog | Feb. 15, 2023
With liquid biopsy, sensitivity matters